Research News

New Immunotherapy Combination May Help Combat Ovarian Cancer Tumors

A therapeutic strategy that targets key tumor proteins shows promise for treating the most common subtype of ovarian cancer, according to a recent study led by OCRA grantee Duygu Ozmadenci, PhD, of the University of California, San…

Read on

Benoît Bragantini, PhD | Meet a Scientist

Dr. Benoît Brangantini, of Mayo Clinic, is a 2021 recipient of OCRA’s Mentored Investigator Grant. With his project, “Probing Homologous Recombination DNA Repair Factors in Chromatin by cryo-EM,” Dr…

Read on

Highlights: 2022 Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer

Submitted by ovarian cancer survivor Annie Ellis, OCRA Research Advocate and Scientific Advisory Committee member This year’s SGO annual meeting was held in Phoenix, Arizona from March 18-21…

Read on

Researchers Discover Genetic Link Between Ovarian Cancer Subtypes and Endometriosis

Some ovarian cancers are genetically linked to the gynecologic disorder known as endometriosis, according to recent findings from an international team of researchers…

Read on

Melanie Weigert, PhD | Meet a Scientist

Dr. Melanie Weigert, of University of Chicago, is a 2021 recipient of OCRA’s Mentored Investigator Grant. With her project, “Genome-Wide Profiling of 5-hydroxymethylcytosine on Cell-Free DNA,” Dr…

Read on

Comprehensive Study Provides Recommendations for Better Ovarian Cancer Patient Care

Key recommendations for improving care of ovarian cancer patients in the United States have been published as part of a collaborative, in-depth initiative spearheaded by the Association of Community Cancer Centers (ACCC) and involving a…

Read on

New Study Shows Surgical Removal of Fallopian Tubes Can Reduce Ovarian Cancer Risk

In promising news on the prevention front, one surgical procedure that leaves the ovaries intact may greatly reduce the risk of ovarian cancer…

Read on

The Overview: February 2022

This may be a short month, but it’s not short on all the many ways to get involved. In the meantime, we hope you feel the Valentine love from all of us at OCRA. ADVOCACY Spring Advocacy Day is right around the corner, March 7th – 8th…

Read on

New Research Shows Cervical Cells May Hold Key to Predicting Ovarian Cancer Risk

Cervical cell samples that are routinely collected as part of Pap smears may hold promise for predicting the risk of ovarian and other cancers, according to recent findings published as two separate papers in Nature — one focused on…

Read on

Study Finds Pfizer-BioNTech COVID-19 Vaccine Safe and Effective for Gynecologic Oncology Patients

A prospective cohort study recently published on Vaccines set out to determine the safety and effectiveness of the Pfizer-BioNTech COVID-19 vaccine for gynecologic cancer patients undergoing chemotherapy treatment around the time of their…

Read on

The Overview | January 2022

Happy new year! While the temperatures may be chilly for many of us, we hope everyone is keeping warm with renewed hope for a year of progress toward our mission, and a strong sense of community…

Read on

OCRA Awards Two Ovarian Cancer Research Prizes

OCRA is pleased to announce the recipients of two research prizes, selected by members of our Scientific Advisory Committee for their notable contributions to the field of ovarian cancer research and commitment to future discoveries. Dr…

Read on
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]